Angela Baljuls

576 total citations
17 papers, 431 citations indexed

About

Angela Baljuls is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Angela Baljuls has authored 17 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Angela Baljuls's work include Melanoma and MAPK Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Ubiquitin and proteasome pathways (5 papers). Angela Baljuls is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Ubiquitin and proteasome pathways (5 papers). Angela Baljuls collaborates with scholars based in Germany, Ireland and Switzerland. Angela Baljuls's co-authors include Ulf R. Rapp, Mirko Hekman, Walter Kölch, Boris Ν. Kholodenko, Andreas Fischer, René P. Zahedi, Albert Sickmann, Renate Metz, Thomas D. Mueller and Jörg Reinders and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and European Journal of Pharmacology.

In The Last Decade

Angela Baljuls

17 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Baljuls Germany 10 394 62 54 44 40 17 431
Gonzalo L. González‐Del Pino United States 5 316 0.8× 55 0.9× 35 0.6× 48 1.1× 54 1.4× 7 401
C-T Yeh Taiwan 7 277 0.7× 75 1.2× 77 1.4× 29 0.7× 18 0.5× 7 389
Alison D. Hindley United Kingdom 7 475 1.2× 104 1.7× 69 1.3× 86 2.0× 56 1.4× 7 550
James R. Porter United States 8 350 0.9× 59 1.0× 46 0.9× 18 0.4× 59 1.5× 12 483
Glen R. Rennie United States 6 214 0.5× 61 1.0× 46 0.9× 29 0.7× 16 0.4× 8 314
Kia Strömberg Sweden 9 323 0.8× 96 1.5× 35 0.6× 18 0.4× 63 1.6× 10 491
Natasha Zarich Spain 10 267 0.7× 60 1.0× 33 0.6× 22 0.5× 14 0.3× 14 363
A.M. Jensen United States 2 454 1.2× 72 1.2× 77 1.4× 30 0.7× 22 0.6× 2 508
Zhanzhan Feng China 14 273 0.7× 102 1.6× 50 0.9× 26 0.6× 21 0.5× 19 395
Ellin‐Kristina Hillert Sweden 8 279 0.7× 106 1.7× 53 1.0× 10 0.2× 26 0.7× 8 418

Countries citing papers authored by Angela Baljuls

Since Specialization
Citations

This map shows the geographic impact of Angela Baljuls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Baljuls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Baljuls more than expected).

Fields of papers citing papers by Angela Baljuls

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Baljuls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Baljuls. The network helps show where Angela Baljuls may publish in the future.

Co-authorship network of co-authors of Angela Baljuls

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Baljuls. A scholar is included among the top collaborators of Angela Baljuls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Baljuls. Angela Baljuls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Augustin, Robert, Anouk Oldenburger, Jens Markus Borghardt, et al.. (2025). Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide. Molecular Metabolism. 99. 102205–102205. 1 indexed citations
2.
Garrett, Lillian, Martin Irmler, Angela Baljuls, et al.. (2023). GPR101 loss promotes insulin resistance and diet-induced obesity risk. Neuroscience Applied. 2. 101126–101126. 1 indexed citations
3.
Baljuls, Angela, et al.. (2023). Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse model. Molecular Metabolism. 74. 101765–101765. 4 indexed citations
4.
Foll, Christelle Le, et al.. (2021). The calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice. European Journal of Pharmacology. 908. 174352–174352. 4 indexed citations
5.
Baljuls, Angela, Maciej Dobrzyński, Jens Rauch, Nora Rauch, & Walter Kölch. (2016). Stabilization of C-RAF:KSR1 complex by DiRas3 reduces availability of C-RAF for dimerization with B-RAF. Cellular Signalling. 28(10). 1451–1462. 6 indexed citations
6.
Mueller, Thomas D., Laxmikanth Kollipara, René P. Zahedi, et al.. (2013). Tyr728 in the Kinase Domain of the Murine Kinase Suppressor of RAS 1 Regulates Binding and Activation of the Mitogen-activated Protein Kinase Kinase. Journal of Biological Chemistry. 288(49). 35237–35252. 3 indexed citations
7.
Baljuls, Angela, Boris Ν. Kholodenko, & Walter Kölch. (2012). It takes two to tango – signalling by dimeric Raf kinases. Molecular BioSystems. 9(4). 551–558. 36 indexed citations
8.
Baljuls, Angela, Mattias Beck, Ruth Kroschewski, et al.. (2012). The Tumor Suppressor DiRas3 Forms a Complex with H-Ras and C-RAF Proteins and Regulates Localization, Dimerization, and Kinase Activity of C-RAF. Journal of Biological Chemistry. 287(27). 23128–23140. 12 indexed citations
9.
Sanges, Carmen, René P. Zahedi, Albert Sickmann, et al.. (2012). Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. Cell Death and Disease. 3(3). e276–e276. 39 indexed citations
10.
Baljuls, Angela, et al.. (2011). Single Substitution within the RKTR Motif Impairs Kinase Activity but Promotes Dimerization of RAF Kinase. Journal of Biological Chemistry. 286(18). 16491–16503. 32 indexed citations
11.
Baljuls, Angela, et al.. (2011). BAD Contributes to RAF-mediated Proliferation and Cooperates with B-RAF-V600E in Cancer Signaling. Journal of Biological Chemistry. 286(20). 17934–17944. 15 indexed citations
12.
Molzan, Manuela, Benjamin Schumacher, Angela Baljuls, et al.. (2010). Impaired Binding of 14-3-3 to C-RAF in Noonan Syndrome Suggests New Approaches in Diseases with Increased Ras Signaling. Molecular and Cellular Biology. 30(19). 4698–4711. 101 indexed citations
13.
Baljuls, Angela, Jochen Kuper, Roland Benz, et al.. (2010). Pore-forming activity of BAD is regulated by specific phosphorylation and structural transitions of the C-terminal part. Biochimica et Biophysica Acta (BBA) - General Subjects. 1810(2). 162–169. 4 indexed citations
14.
Baljuls, Angela, Ulrike Rennefahrt, Andreas Fischer, et al.. (2009). Identification of Novel in Vivo Phosphorylation Sites of the Human Proapoptotic Protein BAD. Journal of Biological Chemistry. 284(41). 28004–28020. 47 indexed citations
15.
Fischer, Andreas, Angela Baljuls, Jörg Reinders, et al.. (2008). Regulation of RAF Activity by 14-3-3 Proteins. Journal of Biological Chemistry. 284(5). 3183–3194. 69 indexed citations
16.
Baljuls, Angela, Werner Schmitz, Thomas D. Mueller, et al.. (2008). Positive Regulation of A-RAF by Phosphorylation of Isoform-specific Hinge Segment and Identification of Novel Phosphorylation Sites. Journal of Biological Chemistry. 283(40). 27239–27254. 30 indexed citations
17.
Baljuls, Angela, Thomas D. Mueller, Hannes C. A. Drexler, Mirko Hekman, & Ulf R. Rapp. (2007). Unique N-region Determines Low Basal Activity and Limited Inducibility of A-RAF Kinase. Journal of Biological Chemistry. 282(36). 26575–26590. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026